Returns
-5.60%
Loading chart...
Fundamentals
Large Cap
Financial - Banking
Market Cap (Cr)
1095.29
Earning Per Share
114.19
Dividend Yield
0.06%
P/E Ratio
60.42
P/B Ratio
13.35
Debt to Equity
0.09
Performance
min-value
max-value
Open
56,601.30
52-wk High
75,250.00
High
56,601.30
52-wk Low
75,250.00
Low
56,601.30
Band
75,250.00
Lower Circuit
56,601.30
Upper Circuit
75,250.00
Volume
56,601.30
VWAP
75,250.00
52 Week Performance
min-value
max-value

5.34% down side
up side5.34%

About the company
Remus Pharmaceuticals Limited was originally incorporated as Remus Pharmaceuticals Private Limited' as a Private Limited Company, vide Certificate of Incorporation dated September 21, 2015, issued by the Assistant Registrar of Companies, Gujarat. Subsequently, Company converted from a Private to Public and the name of the Company was changed to 'Remus Pharmaceuticals Limited' on January 06, 2023 by the Registrar of Companies, Ahmedabad. The Company is engaged in marketing & distribution of finished formulations of pharmaceutical drugs. It deals in API (Active Pharmaceutical Ingredient), provide technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries. The Company deal in drug forms like Capsules, Cream, Eye Drops, Gel, Infusion, Inhalation, Inhaler, Injection, Nail Lacquer, Nasal Solution, Nasal Spray, Nebuliser, Ointment, Ophthalmic, Oral Gel, Oral Solution, Oral Suspension, Sachet, Suspension, Tablet.